drugset / Trial / NCT00518479

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

NCT00518479

RandomizedParallel-groupOpen-labelTreatment

Summary

Uncontrolled high blood pressure can cause heart muscle 'thickening', and this increases the likelihood of complications and death. The high blood pressure explains some but not all of this increase in heart size. This study will investigate the other causes, and will measure the heart muscle 'thickness' very accurately using the latest and most accurate technique called cardiac magnetic resonance imaging (MRI). The best way to treat this heart thickening remains to be determined. We hope to be able to show that by specifically targeting the cause of heart muscle thickening we can reduce its occurrence more effectively than by other standard means of blood pressure treatment

Timeline

Start
2003-09
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg
Subject Bendroflumethiazide Small molecule 2.5 mg
Subject Moxonidine Small molecule 400 ug
Subject Valsartan Small molecule 160 mg